Skip to content

Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults-2

Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults: Randomized Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03187340
Acronym
MBAT-2
Enrollment
112
Registered
2017-06-14
Start date
2019-06-20
Completion date
2025-12-31
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Brief summary

Insomnia can be a chronic problem that leads to significant daytime fatigue, stress and numerous negative health consequences including depression. Advanced Medical Electronics, in partnership with researchers are the University of Pennsylvania, propose developing an innovative, non-drug, low-risk, intervention that can be implemented on mobile devices for the treatment of insomnia

Interventions

BEHAVIORALSleep education and relaxation 1

Sleep hygiene and relaxation training; Sleep education and relaxation 1

BEHAVIORALSleep education and relaxation 2

Modified sleep hygiene and relaxation training; Sleep education and relaxation 2

Sponsors

Advanced Medical Electronics
CollaboratorOTHER
Nalaka Gooneratne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1) Sleep onset latency \> 30 min for at least 3 nights per week

Exclusion criteria

1) Unable to perform tests due to inability to communicate verbally/blindness, inability to write and read in English (the study questionnaires are in English and do not exist in validated form for other languages). 2) Cognitive impairment; cognitively impaired patients may not be able to comply with the protocol). 3) History of a diagnosed non-insomnia sleep disorder, such as sleep apnea or circadian rhythm disorder 4) Upper extremity motor impairment that would preclude MBAT therapy (e.g., quadriplegia).

Design outcomes

Primary

MeasureTime frameDescription
Sleep onset latencyfour weekstime to fall asleep

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026